home All News open_in_new Full Article

US Tariffs: Only Sun Pharma Exposed To Some Headline Risk, But With Limited Earnings Impact

Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US, about 17% of 2024-25 revenue.


today 5 d. ago attach_file Events



ID: 1469702770
Add Watch Country

arrow_drop_down